HSJ Medicines Forum

14 October 2022 | Doubletree by Hilton, Tower of London

 

DRAFT PROGRAMME

Establishing a new collaborative operating model to drive value and patient outcomes at a system level

09:00

Registration & Refreshments

09:30

Chair’s Opening Remarks

Dave West, Deputy Editor, HSJ

09.40

Keynote

Building the future of integrated medicines: What does good look like?

The NHS and its industry partners face the biggest upheaval in medicines management and funding in a decade. In this opening keynote, we’ll be examining how the systemisation of the NHS will enable collaborative working and enable real benefits for population health, clinical quality and value, with a review of learnings from IPMO pilots. We’ll also review future decision-making structures at national, regional, ICS and place level, including clarification of the future role of RMOCs in order for systems.

Speaker: 
David Webb, Chief Pharmaceutical Officer, NHS England and NHS Improvement

10:10

Panel Discussion

Working together across key stakeholders and systems to optimise access to innovative medicines

  • Identify and remove duplication and non-value adding processes which slow down innovative medicines reaching patients
  • Removing barriers to support faster implementation of national directives at a local level
  • Exploring the role of the ICS to enable better integrated working
  • Working with industry to bring medicines to the NHS at the right price

Panellists:
Claire Foreman, Director of Medicines Policy & Strategy, NHS England and NHS Improvement
Glenn Wells, Chief Partnerships Officer, MHRA
Paul Catchpole, Director, Value & Access Policy, ABPI
Meindert Boysen, Director, Centre for Health Technology Evaluation, NICE 

10:50

Panel Discussion

Establishing new responsibilities and shared accountability for Specialised Commissioning

  • Next steps for improving the delivery of care for rare diseases
  • How will the new funding system work for high-cost drugs and for allocating long-term funding?
  • What is going to change? Direction of travel, major challenges
  • Integrating specialised services with wider pathways of care
  • Reducing variation in the quality of services at a local level
  • Identifying and addressing skills and knowledge gaps
  • How to access the IMF?

Panellists:
Alison Tennant, Chief Pharmacist, Birmingham Women’s & Children’s NHS Foundation Trust
Mohammed Asghar, ICS Prescribing Governance Lead, Frimley Health & Care 
Inderjit Singh, Chief Pharmacist, University Hospitals Birmingham NHS Foundation Trust
Jatinder Harchowal, Chief Pharmacist, University College London Hospitals NHS Foundation Trust

11.30

Morning Refreshments & Networking

12:00

Interactive Discussion Groups: 
Join one of the following intimate and focused small-group discussions to share experiences with colleagues across the health system. Bringing together 12-15 participants, ensure you sign up early to secure your place at your preferred table. 

1. Realising the benefits of medicines optimisation initiatives across an ICS

- Identifying opportunities, challenges and then the solutions with meds op teams at CCG level, identifying MO initiatives across the ICS
- Delivering on Active Implementation and how to motivate and work with GPs / PCNs to ensure take up and roll out
- Improving patients outcomes and financial benefits to the NHS by improving care
- How to engage with other ICS stakeholders
- What population data resource the ICS would find valuable to support meds op initiatives
Moderator: Selma Abed, Head of Medicines Optimisation, Spirit Health

2. Taking a data driven approach to medicines optimisation

- How are you linking in health inequalities and medicines (prescribing and optimisation)? What data do you need?

- What are the challenges/pain points preventing you doing this at present? – budgets, ICS formations, IG constraints on data sharing etc

- Medicines Optimisation Strategy – how are you linking up ICS, Place and PCN? Learning from ideas and examples round the table?

- What does the future look like? What types of data should be brought in? What’s the aspiration and appetite? What do you want to see? What would help you?

Moderators: Meera Prakash, Clinical Facilitator & Rupinder Gill, Programme Manager - Medicines Optimisation, Optum

3. Translating population health into practice
Featuring: Vishal Mashru, Head PCN Medicines & Research, Cross Counties Healthcare PCN and North Blaby PCN
Moderator: Dave West, Deputy Editor, HSJ

Sponsored by Daiichi Sankyo UK 

4. Removing the barriers to access to medicines
- Understanding the barriers for patient access to new medicines
- What needs to be done to improve access and reduce inequalities?

Moderator: Jyotika Singh, Principal Consultant & Oliver Hudson, Content Director, Wilmington Healthcare

12:40

Networking Lunch

13:40

Panel Discussion

Driving value through an integrated approach to prescribing and medicines

  • Embedding medicines as the golden thread that runs through everything across the ICS to drive value for the patient, clinician and system
  • Approaching and measuring medicines value as a system – what system intelligence do you need?
  • Working together to make an impact in key priority areas:
    • Deprescribing and non-compliance
    • Patient safety, medication errors in prescribing
  • Exploring opportunities for a new collaboration and partnership with local authority
  • Integrated working to support medicines optimisation in patients with severe mental illness and learning disabilities 

Panellists:

Chetan Shah, Chief Pharmacist, Hertfordshire Partnership University NHS Foundation Trust
Ewan Maule, ICS Lead Pharmacist, North East & North Cumbria
Roger Fernandes, Chief Pharmacist & Clinical Director, Kings College Hospital NHS Foundation Trust

14:20

Presentation

Exploring medicines budgeting and funding flows in the new ICS landscape

  • Collaborating and moving money around to focus on outcomes – shared experiences
  • Managing pooled budgets and potential for overspend
  • Redesigning medicines committees, their responsibilities and relationship with the ICB
  • Reviewing roles and budget management accountabilities: ICS vs Provider
  • What are the new funding routes, how are they being managed, how can they be accessed?

Speaker:
Henry Black, Chief Finance Officer, NHS North East London CCG

14:50

Panel Discussion

Designing an ICS medicines and prescribing workforce to enable collaboration and improved medicines use

  • Transitioning from multiple CCGs to one medicines team - standardising the offer and approach, meeting the specific requirements of the ICS
  • Enabling equalisation of resources to ensure safety and continuity of care
  • Working together as one team and developing collaborative relationships with acute providers and mental health trusts
  • Tackling recruitment and retention across the system
  • Supporting training and development of career pathways
  • Integrating community pharmacy and PCN pharmacists and pharmacy technicians into the ICS team
  • What role would (non-NHS) providers play in the delivery of medicines and integration of medicines?

Panellists:

Mildred Johnson, Clinical Director of Pharmacy & Medicines Optimisation, Maidstone & Tunbridge Wells NHS Trust & Chair, Kent, Surrey & Sussex Chief Pharmacists & Medicines Management Leads Network 
Vanessa Burgess, Chief Pharmacist, South East London CCG
Mandeep Butt, Director, Integrated Pharmacy & Medicines  Optimisation Programme, North Central London STP

15:30

Afternoon Refreshments & Networking

16:00

Panel Discussion

Digitising medicines management to enable an integrated and patient-centred approach

  • Establishing a one-patient view across systems
  • The power of connected data for improved communication, safety and continuity of care
  • Establishing interoperability of systems
  • E-prescribing
  • Transforming lives with digital medicines: What lies ahead?

Panellists:

Will Willson, Director of Pharmacy, East Kent Hospital University Foundation Trust
Julian Wyatt, Project Lead, Lancashire & South Cumbria ICS
Liz Butterfield, Pharmacy Advisor, Kent Surrey Sussex Academic Health Science Network

16:40

Panel Discussion

Addressing health inequalities through effective prescribing

  • What does population health management mean and how does it relate to pharmacy and medicines?
  • Understanding how to utilise data and analytics to identify opportunities to drive better health outcomes
  • Evaluating key national public health priorities - and how a Population Health approach could drive positive change
  • Identifying opportunities to intervene earlier with medicines
  • Changing approaches to investment and value
  • Optimising the role of community pharmacy to improve Population Health

Panellists:

Yousaf Ahmad, Chief Pharmacist & Director of Medicines Optimisation, NHS Frimley Health & Social Care
Raliat Onatade, Chief Pharmacist and Director of Medicines and Pharmacy, North East London CCG/ICS & Group Chief Pharmacist and Clinical Director for Medicines Optimisation, Barts Health NHS Trust 
Helen Kilminster, Senior Clinical Pharmacist, Tower Hill Medical Practice & Vice President, Primary Care Pharmacy Association 

17:20

Chair’s Closing Remarks

Dave West, Deputy Editor, HSJ